A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.
暂无分享，去创建一个
Philip R. Johnson | S. Kochhar | J. van Lunzen | R. Paranjape | J. Rockstroh | J. Excler | N. Clumeck | M. Thakar | S. Mehendale | P. Fast | M. Peeters | M. Boaz | J. Gilmour | A. Heald | J. Lehrman | C. Schmidt | S. Sahay | Mark J. Boaz | C. Schwarze‐Zander | T. Glaunsinger | E. Vets | P. Anklesaria | B. Barin | K. Kabamba